ResAppDx
- UID
- IMP/MD/2022/000517_0c421af028752f744cdf59c028121cd4_ebcc949aa965ef05344207334cd186e8
- Device class
- Class B
- Brand name
- ResAppDx
- License holder
- M/S ASIA ACTUAL INDIA (OPC) PVT. LTD.
- Approving authority
- CDSCO
- Product information
- ResAppDx is a mobile medical software application (ResAppDx) that analyses cough sounds to aid in diagnosis of a set of respiratory diseases in patients aged 29 days or older by a healthcare provider. The set of respiratory diseases detected are: lower respiratory tract disease, asthma exacerbation/reactive airway disease (ResAppDx), croup (ResAppDx), pneumonia (ResAppDx), bronchiolitis (ResAppDx), COPD (ResAppDx). On iOS platform and select Android devices, COPD exacerbation (ResAppDx) is also detected. ResAppDx is to be used on patients aged 29 days or older who produce involuntary/spontaneous coughs or are able to cooperate in providing voluntary cough sounds. The device provides a qualitative output based on cough analysis to the healthcare provider. ResAppDx is for use under the supervision of a healthcare provider. ResAppDx may be used either directly in a clinic or Emergency Department, or remotely via the telehealth platform.
ResAppDx is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2022/000517_0c421af028752f744cdf59c028121cd4_ebcc949aa965ef05344207334cd186e8. This device is marketed under the brand name ResAppDx. The license holder is M/S ASIA ACTUAL INDIA (OPC) PVT. LTD., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.